Molecular Mechanisms of MYCN Dysregulation in Cancers
MYCN, a member of MYC proto-oncogene family, encodes a basic helix-loop-helix transcription factor N-MYC. Abnormal expression of N-MYC is correlated with high-risk cancers and poor prognosis. Initially identified as an amplified oncogene in neuroblastoma in 1983, the oncogenic effect of N-MYC is exp...
Main Authors: | Ruochen Liu, Pengfei Shi, Zhongze Wang, Chaoyu Yuan, Hongjuan Cui |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.625332/full |
Similar Items
-
The Role of MYCN in Symmetric vs. Asymmetric Cell Division of Human Neuroblastoma Cells
by: Hideki Izumi, et al.
Published: (2020-10-01) -
Targeting MYCN in Pediatric and Adult Cancers
by: Zhihui Liu, et al.
Published: (2021-02-01) -
MYCN in Neuroblastoma: “Old Wine into New Wineskins”
by: Maria Braoudaki, et al.
Published: (2021-10-01) -
Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy
by: Anders Valind, et al.
Published: (2023-12-01) -
MYCN Amplification Is Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in Neuroblastoma
by: Prasoon Agarwal, et al.
Published: (2023-05-01)